— Know what they know.
/
Not Investment Advice

HROW NASDAQ

Harrow Health, Inc.
1W: +3.6% 1M: -8.0% 3M: -24.8% YTD: -41.8% 1Y: -24.5% 3Y: +101.9% 5Y: +189.0%
$29.07
+0.12 (+0.41%)
Pre-Market: $29.30 (+0.23, +0.79%)
Weekly Expected Move ±5.5%
$25 $27 $28 $30 $32
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 39 · $1.1B mcap · 29M float · 2.12% daily turnover · Short 67% of daily vol
Credit Risk of going bust: higher than 70% of companies Debt: 21.6% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.96 (down 97%), Harrow Health, Inc. would be worth roughly what it owes.
Total debt $300.7M against a stock market value of $1.09B.
Distance to default 3.45 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $146.2M (short-term plus half of long-term), stock volatility 65.5%; Altman Z 1.89. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview News Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings
Dividends Analysis Technicals Weather Peers ESG Institutions ETF Exposure Dark Pool Short Interest Supply Chain

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NARROW EDGE
58.1 / 100
NoneWeakNarrowWide
Primary source: Switching Costs  ·  ROIC: 1.9%  ·  5Y Avg: 256.4%
Cost Advantage
55
Intangibles
59
Switching Cost
70
Network Effect
47
Scale
52
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. HROW has a Narrow competitive edge (58.1/100) — meaningful but not impregnable advantages over competitors. The primary source of advantage is Switching Costs. ROIC of 1.9% suggests modest returns relative to capital deployed.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$45
Low
$45
Avg Target
$45
High
Based on 1 analyst since Aug 10, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 10Hold: 0Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$45.00
Analysts1
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-09-09 Leerink Partners — Initiated $45 — +18.9% $37.85
2026-05-13 Cantor Fitzgerald Steve Seedhouse $94 $88 -6 +205.7% $28.79
2026-03-18 BTIG Thomas Shrader Initiated $63 — +81.7% $34.68
2026-03-04 H.C. Wainwright Yi Chen $64 $70 +6 +76.7% $39.62
2025-11-11 Cantor Fitzgerald — $76 $94 +18 +142.6% $38.74
2025-09-29 Lake Street Thomas Flaten $55 $70 +15 +48.6% $47.10
2025-09-23 Craig-Hallum Chase Knickerbocker $45 $64 +19 +30.8% $48.93
2025-08-13 H.C. Wainwright Yi Chen Initiated $64 — +83.7% $34.83
2025-07-11 Cantor Fitzgerald Steve Seedhouse Initiated $76 — +117.6% $34.93
2024-10-18 B.Riley Financial Sahil Kazmi Initiated $73 — +29.4% $56.41
2024-10-04 Lake Street Brooks O'Neil $25 $55 +30 +10.6% $49.75
2024-08-09 Craig-Hallum Chase Knickerbocker $30 $45 +15 +27.7% $35.25
2024-06-21 Craig-Hallum Chase Knickerbocker Initiated $30 — +50.5% $19.93
2024-06-03 Loop Capital Markets Brooks O'Neil Initiated $25 — +41.4% $17.68
2024-06-03 Lake Street Brooks O'Neil Initiated $25 — +37.9% $18.12

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C-
Oct 27, 2026
DCF
3
ROE
1
ROA
1
D/E
1
P/E
1
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. HROW receives an overall rating of C-. Areas of concern: ROE (1/5), ROA (1/5), D/E (1/5), P/E (1/5), P/B (1/5).

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 31 Grade D
Profitability
20
Balance Sheet
32
Earnings Quality
35
Growth
49
Value
32
Momentum
48
Safety
65
Cash Flow
38
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. HROW scores highest in Safety (65/100) and lowest in Profitability (20/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
2.64
Grey Zone
Piotroski F-Score
5/9
✗ ✓ ✗ ✓ ✗ ✓ ✓ ✗ ✓
Beneish M-Score
-2.53
Unlikely Manipulator
Ohlson O-Score
-3.22
Bankruptcy prob: 3.8%
Low Risk
Credit Rating
B+
Score: 34.1/100
Trend: Improving
Earnings Quality
—
OCF/NI: -0.17x
Accruals: -11.4%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. HROW scores 2.64, placing it in the Grey Zone (safe > 2.99, distress < 1.81). Financial distress is possible and warrants monitoring. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. HROW scores 5/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. HROW's score of -2.53 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. HROW's implied 3.8% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. HROW receives an estimated rating of B+ (score: 34.1/100), with a improving trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-29.29x
PEG
0.54x
P/S
3.95x
P/B
71.43x
P/FCF
278.24x
P/OCF
253.72x
EV/EBITDA
169.04x
EV/Revenue
6.54x
EV/EBIT
-172.61x
EV/FCF
316.28x
Earnings Yield
-2.35%
FCF Yield
0.36%
Shareholder Yield
0.00%
Graham Number
—
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. HROW currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.114
NI / EBT
×
Interest Burden
3.200
EBT / EBIT
×
EBIT Margin
-0.038
EBIT / Rev
×
Asset Turnover
0.723
Rev / Assets
×
Equity Multiplier
11.747
Assets / Equity
=
ROE
-114.8%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. HROW's ROE of -114.8% is driven by financial leverage (equity multiplier: 11.75x). Note: high leverage means ROE is amplified by debt rather than operational performance. A tax burden ratio of 1.11 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
—
Price/Value
—
Margin of Safety
—
Premium
—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$29.07
Median 1Y
$29.21
5th Pctile
$9.10
95th Pctile
$94.39
Ann. Volatility
68.6%
Analyst Target
$45.00
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Mark L. Baum
Chief Executive Officer
 $731,120 $— $1,358,490
Andrew R. Boll
Chief Financial Officer and Corporate Secretary
 $491,920 $— $849,201
John P. Saharek
President and Chief Executive Officer, ImprimisRx
 $463,431 $— $743,467

CEO Pay Ratio

3:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $1,358,490
Avg Employee Cost (SGA/emp): $409,957
Employees: 373

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
373
-2.4% YoY
Revenue / Employee
$730,035
Rev: $272,303,000
Profit / Employee
$-13,777
NI: $-5,139,000
SGA / Employee
$409,957
Avg labor cost proxy
R&D / Employee
$40,354
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE -45.1% -93.6% -1.1% -1.7% -2.5% -72.5% -1.1% -1.2% -36.9% -49.8% -76.0% -83.0% -50.0% -25.0% -37.1% -18.9% -9.5% -8.4% -35.1% -1.1% -1.15%
ROA -11.6% -23.1% -26.9% -23.8% -22.4% -11.0% -11.6% -10.1% -7.4% -10.4% -12.2% -12.7% -10.5% -5.0% -6.6% -3.1% -1.4% -1.3% -3.8% -9.8% -9.77%
ROIC 18.7% 3.3% 1.6% -3.9% 4.7% 4.0% 0.5% 0.8% 1.5% 0.2% -3.5% -3.7% -3.9% 2.8% 1.6% 5.1% 9.8% 13.3% 9.5% 1.9% 1.94%
ROCE 7.7% 3.8% 2.9% 0.1% 4.6% 1.4% 0.5% 0.8% 1.3% 0.3% -2.9% -3.2% -3.3% 3.0% 2.7% 15.2% 6.8% 7.5% 3.6% -3.3% -3.32%
Gross Margin 73.6% 74.8% 73.0% 72.0% 70.6% 69.7% 68.3% 70.1% 70.6% 68.9% 69.5% 74.4% 75.6% 78.8% 67.5% 74.5% 75.3% 79.3% 61.2% 71.3% 71.27%
Operating Margin -19.9% -8.7% 9.5% 7.2% -0.4% -8.7% 4.6% 7.0% 5.1% -13.4% -20.0% 3.1% 2.7% 19.3% -23.5% 17.9% 20.6% 27.0% -50.0% -15.6% -15.58%
Net Margin -44.5% -36.7% -11.0% -26.8% -28.3% 5.2% -25.4% -12.6% -12.8% -25.2% -39.2% -13.2% -8.6% 10.1% -37.2% 7.8% 1.4% 7.4% -62.4% -24.4% -24.44%
EBITDA Margin -17.5% 2.0% 13.0% 10.6% 2.1% -5.3% 14.0% 16.2% 13.5% -4.8% -11.8% 8.9% 8.7% 26.3% -14.0% 25.1% 16.2% 22.9% -37.3% -6.8% -6.83%
FCF Margin 6.3% -32.3% -32.6% -30.3% -27.8% -1.0% -11.0% -11.2% -27.4% -14.0% -10.3% -13.4% 1.8% -30.5% -17.2% -15.2% -8.2% 15.8% 5.3% 2.1% 2.07%
OCF Margin 9.0% 7.0% 3.6% 2.7% 4.4% 1.9% -8.1% -7.6% -7.5% 2.9% 5.4% 0.1% 2.5% -11.1% 1.0% 1.8% 7.1% 16.1% 5.7% 2.3% 2.27%
ROE 3Y Avg snapshot only -1.08%
ROE 5Y Avg snapshot only -1.64%
ROA 3Y Avg snapshot only -7.62%
ROIC 3Y Avg snapshot only -18.02%
ROIC Economic snapshot only 1.45%
Cash ROA snapshot only 1.50%
Cash ROIC snapshot only 2.69%
CROIC snapshot only 2.46%
NOPAT Margin snapshot only 1.63%
Pretax Margin snapshot only -12.13%
R&D / Revenue snapshot only 7.46%
SGA / Revenue snapshot only 50.74%
SBC / Revenue snapshot only 2.57%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio -26.11 -13.18 -8.99 -8.14 -14.63 -30.84 -35.04 -35.62 -34.65 -16.22 -14.98 -22.16 -48.05 -68.72 -43.92 -116.01 -375.50 -350.51 -87.75 -42.61 -29.290
P/S Ratio 3.68 3.28 2.35 2.36 3.73 4.90 6.92 5.65 4.31 3.04 3.38 4.83 9.49 6.02 4.48 5.21 7.49 6.61 4.89 5.76 3.954
P/B Ratio 14.86 21.03 18.40 34.57 271.25 15.74 29.29 25.88 6.50 5.63 7.75 12.71 27.69 17.25 16.88 23.90 39.84 34.35 45.73 104.36 71.433
P/FCF 58.85 -10.14 -7.19 -7.78 -13.42 -479.41 -62.97 -50.60 -15.72 -21.71 -32.93 -36.02 529.76 -19.76 -26.02 -34.39 -91.48 41.95 91.85 278.24 278.244
P/OCF 41.04 46.71 65.36 87.91 84.06 254.75 — — — 103.12 63.19 6527.03 375.65 — 455.10 293.93 105.97 41.06 86.34 253.72 253.722
EV/EBITDA 27.96 51.85 46.64 91.27 57.96 93.62 143.49 85.96 48.23 42.16 138.35 271.73 607.81 62.50 57.21 43.78 53.32 47.98 48.26 169.04 169.038
EV/Revenue 3.82 3.65 2.71 2.70 4.09 5.02 8.54 7.08 5.33 3.87 4.22 5.61 10.22 6.93 5.24 5.98 8.20 7.27 5.65 6.54 6.543
EV/EBIT 35.88 78.70 84.09 3344.72 97.93 231.74 769.25 430.58 172.36 621.09 -79.84 -106.20 -201.66 152.39 233.97 92.97 100.58 86.79 126.88 -172.61 -172.614
EV/FCF 60.94 -11.30 -8.29 -8.91 -14.70 -490.85 -77.69 -63.49 -19.41 -27.62 -41.05 -41.90 570.50 -22.74 -30.48 -39.47 -100.16 46.12 106.26 316.28 316.282
Earnings Yield -3.8% -7.6% -11.1% -12.3% -6.8% -3.2% -2.9% -2.8% -2.9% -6.2% -6.7% -4.5% -2.1% -1.5% -2.3% -0.9% -0.3% -0.3% -1.1% -2.3% -2.35%
FCF Yield 1.7% -9.9% -13.9% -12.8% -7.5% -0.2% -1.6% -2.0% -6.4% -4.6% -3.0% -2.8% 0.2% -5.1% -3.8% -2.9% -1.1% 2.4% 1.1% 0.4% 0.36%
PEG Ratio snapshot only 0.538
EV/OCF snapshot only 288.408
EV/Gross Profit snapshot only 8.928
Acquirers Multiple snapshot only 316.282
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 8.70 6.24 6.79 5.01 3.49 6.35 2.92 2.62 5.80 2.82 3.00 2.60 1.55 2.08 0.91 0.62 2.72 2.20 2.48 2.24 2.244
Quick Ratio 8.32 5.81 6.31 4.61 3.20 6.00 2.41 2.25 5.33 2.60 2.75 2.43 1.44 1.96 0.85 0.58 2.52 2.06 2.30 2.08 2.079
Debt/Equity 4.61 6.91 7.84 13.98 66.12 4.07 8.08 7.92 2.50 2.71 3.16 3.29 3.38 3.29 4.07 4.66 5.36 4.80 10.47 19.79 19.786
Net Debt/Equity 0.53 2.42 2.82 4.99 25.75 0.38 6.85 6.59 1.53 1.53 1.91 2.07 2.13 2.61 2.89 3.53 3.78 3.41 7.18 14.27 14.267
Debt/Assets 0.74 0.79 0.81 0.82 0.81 0.71 0.81 0.79 0.66 0.61 0.65 0.63 0.56 0.59 0.63 0.67 0.69 0.63 0.72 0.72 0.722
Debt/EBITDA 8.38 15.27 17.23 32.25 12.90 23.63 32.07 20.96 15.05 15.94 45.33 60.39 68.94 10.34 11.79 7.43 6.55 6.10 9.55 28.19 28.194
Net Debt/EBITDA 0.96 5.35 6.20 11.51 5.03 2.18 27.19 17.45 9.19 9.02 27.36 38.11 43.41 8.21 8.37 5.64 4.62 4.34 6.55 20.33 20.330
Interest Coverage 1.70 0.62 0.38 0.01 0.50 0.26 0.10 0.12 0.20 0.04 -0.33 -0.37 -0.40 0.40 0.20 0.59 0.80 0.94 0.52 -0.45 -0.454
Equity Multiplier 6.20 8.71 9.67 17.06 81.34 5.70 9.94 10.00 3.78 4.43 4.88 5.24 6.06 5.58 6.45 6.95 7.72 7.62 14.62 27.42 27.422
Cash Ratio snapshot only 0.821
Debt Service Coverage snapshot only 0.464
Cash to Debt snapshot only 0.279
FCF to Debt snapshot only 0.019
Defensive Interval snapshot only 376.5 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.82 0.93 1.03 0.82 0.88 0.69 0.59 0.64 0.59 0.56 0.54 0.58 0.53 0.57 0.65 0.70 0.70 0.69 0.69 0.72 0.723
Inventory Turnover 4.32 4.45 4.59 4.99 5.28 4.72 4.11 4.55 4.86 4.55 4.21 4.95 4.86 4.57 5.04 5.52 5.53 5.61 5.11 5.17 5.174
Receivables Turnover 21.06 20.32 17.12 16.12 16.23 16.53 10.23 8.21 9.06 6.13 6.75 4.39 4.69 2.62 4.02 3.48 3.81 2.40 3.01 2.79 2.793
Payables Turnover 3.35 4.13 3.79 3.78 4.15 4.37 2.86 3.36 5.28 2.85 3.18 2.90 2.97 1.64 2.18 2.66 2.87 1.83 2.20 2.56 2.562
DSO 17 18 21 23 22 22 36 44 40 60 54 83 78 140 91 105 96 152 121 131 130.7 days
DIO 84 82 80 73 69 77 89 80 75 80 87 74 75 80 72 66 66 65 71 71 70.5 days
DPO 109 88 96 97 88 84 128 109 69 128 115 126 123 223 167 137 127 199 166 142 142.5 days
Cash Conversion Cycle -7 12 5 -1 4 16 -3 16 46 11 26 31 30 -4 -4 34 35 18 27 59 58.8 days
Fixed Asset Turnover snapshot only 26.617
Operating Cycle snapshot only 201.2 days
Cash Velocity snapshot only 3.285
Capital Intensity snapshot only 1.512
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 42.7% 48.3% 50.8% 34.8% 32.3% 22.2% 17.0% 21.8% 29.1% 47.0% 49.8% 50.1% 48.1% 53.3% 53.5% 47.7% 47.8% 36.4% 26.2% 21.1% 21.05%
Net Income -4.1% -4.4% -3.1% -4.2% -1.4% 21.8% 11.5% 33.3% 37.0% -73.3% -71.3% -1.1% -1.4% 28.4% 30.8% 69.5% 85.1% 70.6% 31.0% -2.6% -2.64%
EPS -4.1% -4.0% -3.1% -4.2% -1.4% 27.0% 20.4% 40.2% 49.7% -44.2% -46.3% -76.4% -1.3% 29.3% 31.4% 72.1% 86.3% 71.4% 33.6% -2.8% -2.79%
FCF 6.8% -10.3% -15.9% -3.8% -6.9% 96.1% 60.6% 55.1% -27.4% -19.1% -40.0% -80.2% 1.1% -2.3% -1.6% -67.0% -7.8% 1.7% 1.4% 1.2% 1.17%
EBITDA 2.1% -56.7% -70.0% -88.8% -31.7% -6.9% 20.0% 2.4% 1.0% 1.5% -23.3% -62.4% -77.4% 85.2% 3.6% 8.8% 12.5% 86.5% 61.3% -65.7% -65.72%
Op. Income 5.6% 3.2% -79.7% -1.1% -67.6% 18.9% 28.8% 2.0% 81.7% -77.5% -8.5% -6.0% -3.5% 19.5% 1.6% 2.7% 4.1% 3.4% 5.2% -60.4% -60.40%
OCF Growth snapshot only 54.87%
Asset Growth snapshot only 20.80%
Equity Growth snapshot only -69.39%
Debt Growth snapshot only 30.05%
Shares Change snapshot only -3.87%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y 21.5% 20.5% 20.9% 20.7% 21.0% 20.1% 22.2% 31.4% 34.5% 38.6% 38.2% 35.1% 36.2% 40.2% 39.1% 39.2% 41.4% 45.4% 42.6% 39.0% 38.95%
Revenue 5Y 30.5% 29.4% 29.6% 29.0% 28.5% 27.0% 25.7% 25.4% 25.1% 25.8% 25.4% 26.3% 27.6% 31.3% 33.2% 38.2% 39.8% 41.0% 38.6% 34.5% 34.52%
EPS 3Y — — — — — — — — — — — — — — — — — — — — —
EPS 5Y — — — — — — — — — — — — — — — — — — — — —
Net Income 3Y — — — — — — — — — — — — — — — — — — — — —
Net Income 5Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 3Y — — -25.2% -37.3% — 23.7% — — 12.1% 0.4% -34.9% -47.7% -32.2% 63.1% 62.0% 1.3% 83.4% 1.1% 78.7% 8.0% 8.01%
EBITDA 5Y — — — — — — — — — — -17.4% -20.6% — 54.5% — — 33.9% 28.5% 15.5% -13.7% -13.66%
Gross Profit 3Y 32.4% 29.7% 27.3% 26.5% 25.2% 22.5% 23.8% 32.5% 34.4% 38.1% 36.7% 32.9% 35.1% 40.5% 39.3% 40.0% 42.7% 47.9% 45.3% 41.3% 41.31%
Gross Profit 5Y 41.0% 39.9% 40.5% 39.9% 39.6% 36.6% 33.5% 31.8% 30.0% 29.5% 27.7% 29.2% 30.3% 34.3% 35.9% 40.7% 41.6% 42.8% 39.4% 34.0% 34.00%
Op. Income 3Y — — — — — — — — — 3.8% — — — 76.2% 78.2% — 1.4% 1.7% 2.0% 50.0% 49.98%
Op. Income 5Y — — — — — — — — — — — — — — — — — 1.5% 48.2% -12.8% -12.80%
FCF 3Y — — — — — — — — — — — — -10.2% — — — — — — — —
FCF 5Y — — — — — — — — — — — — — — — — — — 52.5% -8.7% -8.71%
OCF 3Y 1.4% 94.8% 1.5% — — 21.5% — — — — 40.8% -78.0% -10.7% — -9.7% 21.3% 65.1% 2.0% — — —
OCF 5Y — — — — — — — — — 41.1% 1.1% — — — 2.2% — 73.7% — 41.7% -10.3% -10.27%
Assets 3Y 53.7% 25.7% 13.6% 14.6% 21.9% 38.6% 66.8% 65.5% 68.8% 75.7% 73.8% 42.1% 50.7% 58.2% 55.1% 52.1% 54.2% 36.4% 24.5% 23.0% 23.00%
Assets 5Y 36.7% 29.3% 30.4% 28.9% 30.4% 45.8% 59.3% 53.4% 58.8% 44.5% 34.8% 36.3% 45.1% 45.8% 50.7% 47.5% 43.6% 47.4% 49.5% 31.3% 31.26%
Equity 3Y 55.0% -23.0% -35.2% -45.3% -63.0% -0.1% 12.6% 12.5% 44.2% 37.3% 29.0% 36.1% 51.8% 83.4% 77.5% 1.1% 2.4% 23.9% 9.5% -12.1% -12.13%
Book Value 3Y 43.9% -26.1% -35.7% -46.7% -63.8% -4.3% 6.8% 6.6% 33.3% 23.5% 18.5% 23.7% 38.5% 67.9% 62.0% 82.4% 2.0% 15.0% 2.2% -17.9% -17.91%
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability 0.93 0.92 0.91 0.91 0.91 0.93 0.94 0.94 0.91 0.85 0.85 0.86 0.86 0.83 0.84 0.89 0.90 0.92 0.93 0.94 0.940
Earnings Stability 0.22 0.00 0.00 0.02 0.07 0.25 0.16 0.18 0.45 0.91 0.52 0.55 0.86 0.70 0.17 0.05 0.13 0.01 0.29 0.41 0.413
Margin Stability 0.85 0.85 0.85 0.84 0.84 0.85 0.87 0.88 0.90 0.92 0.94 0.94 0.95 0.95 0.96 0.96 0.97 0.96 0.97 0.97 0.970
Rev. Growth Consistency 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 0.00 0.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.50 0.50 0.20 0.20 0.50 0.91 0.50 0.50 0.85 0.50 0.50 0.50 0.50 0.89 0.88 0.50 0.50 0.50 0.88 0.50 0.500
Earnings Smoothness — — — — — — — — — — — — — — — — — — — — —
ROE Trend -0.86 -1.54 -1.44 -3.71 -18.22 0.35 0.01 1.24 9.37 0.71 0.92 1.91 8.79 0.18 0.29 0.44 0.28 0.20 -0.07 -2.06 -2.059
Gross Margin Trend 0.07 0.06 0.04 0.02 0.00 -0.01 -0.03 -0.04 -0.04 -0.04 -0.02 -0.00 0.01 0.05 0.05 0.04 0.03 0.03 0.02 0.00 0.004
FCF Margin Trend 0.09 -0.29 -0.34 -0.34 -0.30 0.17 0.04 -0.03 -0.17 0.03 0.12 0.07 0.29 -0.23 -0.07 -0.03 0.05 0.38 0.19 0.16 0.163
Sustainable Growth Rate — — — — — — — — — — — — — — — — — — — — —
Internal Growth Rate — — — — — — — — — — — — — — — — — — — — —
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income -0.64 -0.28 -0.14 -0.09 -0.17 -0.12 0.41 0.48 0.60 -0.16 -0.24 -0.00 -0.13 1.27 -0.10 -0.39 -3.54 -8.54 -1.02 -0.17 -0.168
FCF/OCF 0.70 -4.61 -9.10 -11.29 -6.26 -0.53 1.36 1.48 3.66 -4.75 -1.92 -181.19 0.71 2.74 -17.49 -8.55 -1.16 0.98 0.94 0.91 0.912
FCF/Net Income snapshot only -0.153
OCF/EBITDA snapshot only 0.586
CapEx/Revenue 2.7% 39.3% 36.2% 33.0% 32.2% 2.9% 2.9% 3.6% 19.9% 17.0% 15.6% 13.5% 0.7% 19.3% 18.2% 16.9% 15.3% 0.3% 0.3% 0.2% 0.20%
CapEx/Depreciation snapshot only 0.026
Accruals Ratio -0.19 -0.30 -0.31 -0.26 -0.26 -0.12 -0.07 -0.05 -0.03 -0.12 -0.15 -0.13 -0.12 0.01 -0.07 -0.04 -0.06 -0.12 -0.08 -0.11 -0.114
Sloan Accruals snapshot only 0.525
Cash Flow Adequacy snapshot only 11.347
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 0.1% 0.1% 0.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio — — — — — — — — — — — — — — — — — — — — —
FCF Payout Ratio 3.0% — — — — — — — — — — — 0.0% — — — — 0.0% 0.0% 0.0% 0.00%
Total Payout Ratio — — — — — — — — — — — — — — — — — — — — —
Div. Increase Streak 0 0 0 — — — — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield 1.3% 1.3% 2.1% 0.4% 0.3% 0.2% 0.1% 0.1% 0.1% 0.2% 0.2% 0.2% 0.1% 0.2% 0.1% 1.2% 0.7% 0.7% 1.0% 0.0% 0.00%
Net Buyback Yield 1.3% 1.3% 2.1% 0.4% 0.3% -5.2% -3.5% -3.9% -4.6% 0.2% 0.2% 0.1% 0.1% 0.2% 0.1% 1.2% 0.7% 0.7% 0.9% -0.0% -0.02%
Total Shareholder Return 1.3% 1.4% 2.2% 0.4% 0.3% -5.2% -3.5% -3.9% -4.6% 0.2% 0.2% 0.1% 0.1% 0.2% 0.1% 1.2% 0.7% 0.7% 0.9% -0.0% -0.02%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 1.00 1.01 1.01 1.01 1.01 1.01 0.99 0.98 1.10 1.03 1.03 1.05 1.00 1.01 1.01 0.95 0.91 3.76 1.34 1.11 1.114
Interest Burden (EBT/EBIT) -1.33 -5.31 -8.06 -356.62 -6.06 -7.30 -18.00 -9.79 -3.68 -29.24 4.14 3.92 3.88 -1.91 -4.51 -0.73 -0.27 -0.06 -0.93 3.20 3.200
EBIT Margin 0.11 0.05 0.03 0.00 0.04 0.02 0.01 0.02 0.03 0.01 -0.05 -0.05 -0.05 0.05 0.02 0.06 0.08 0.08 0.04 -0.04 -0.038
Asset Turnover 0.82 0.93 1.03 0.82 0.88 0.69 0.59 0.64 0.59 0.56 0.54 0.58 0.53 0.57 0.65 0.70 0.70 0.69 0.69 0.72 0.723
Equity Multiplier 3.88 4.05 4.02 7.08 11.33 6.58 9.85 11.44 5.00 4.79 6.22 6.56 4.77 5.00 5.64 6.02 6.81 6.46 9.20 11.75 11.747
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $-0.35 $-0.66 $-0.76 $-0.89 $-0.82 $-0.48 $-0.60 $-0.53 $-0.41 $-0.69 $-0.88 $-0.94 $-0.94 $-0.49 $-0.61 $-0.26 $-0.13 $-0.14 $-0.40 $-1.00 $-1.00
Book Value/Share $0.61 $0.41 $0.37 $0.21 $0.04 $0.94 $0.72 $0.74 $2.21 $1.99 $1.71 $1.64 $1.62 $1.95 $1.58 $1.28 $1.21 $1.43 $0.77 $0.41 $0.40
Tangible Book/Share $0.53 $-0.22 $-0.26 $-0.42 $-0.69 $0.05 $-4.38 $-4.20 $-2.55 $-2.54 $-2.80 $-2.77 $-3.74 $-3.28 $-3.52 $-3.32 $-3.27 $-3.35 $-4.13 $-4.34 $-4.34
Revenue/Share $2.47 $2.64 $2.91 $3.09 $3.23 $3.01 $3.06 $3.37 $3.33 $3.68 $3.91 $4.33 $4.74 $5.57 $5.94 $5.86 $6.43 $7.41 $7.22 $7.38 $7.38
FCF/Share $0.15 $-0.85 $-0.95 $-0.94 $-0.90 $-0.03 $-0.34 $-0.38 $-0.91 $-0.52 $-0.40 $-0.58 $0.08 $-1.70 $-1.02 $-0.89 $-0.53 $1.17 $0.38 $0.15 $0.15
OCF/Share $0.22 $0.18 $0.10 $0.08 $0.14 $0.06 $-0.25 $-0.26 $-0.25 $0.11 $0.21 $0.00 $0.12 $-0.62 $0.06 $0.10 $0.45 $1.19 $0.41 $0.17 $0.17
Cash/Share $2.50 $1.84 $1.86 $1.89 $1.80 $3.46 $0.89 $0.97 $2.16 $2.34 $2.14 $1.99 $2.03 $1.32 $1.86 $1.44 $1.91 $1.98 $2.54 $2.25 $2.25
EBITDA/Share $0.34 $0.19 $0.17 $0.09 $0.23 $0.16 $0.18 $0.28 $0.37 $0.34 $0.12 $0.09 $0.08 $0.62 $0.54 $0.80 $0.99 $1.12 $0.85 $0.29 $0.29
Debt/Share $2.82 $2.84 $2.91 $2.94 $2.94 $3.81 $5.83 $5.82 $5.54 $5.39 $5.40 $5.40 $5.49 $6.39 $6.42 $5.95 $6.48 $6.85 $8.08 $8.05 $8.05
Net Debt/Share $0.32 $0.99 $1.05 $1.05 $1.15 $0.35 $4.95 $4.85 $3.38 $3.05 $3.26 $3.41 $3.46 $5.07 $4.56 $4.52 $4.57 $4.87 $5.53 $5.81 $5.81
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 2.636
Altman Z-Prime snapshot only 4.401
Piotroski F-Score 4 5 5 3 3 5 2 3 5 3 6 5 5 4 5 5 5 6 5 5 5
Beneish M-Score -2.51 -1.98 -1.96 -0.89 0.56 -2.57 -0.96 -0.42 -0.54 0.74 -2.10 -1.81 -1.66 -1.02 -1.55 -2.22 -2.41 -3.05 -2.46 -2.53 -2.534
Ohlson O-Score snapshot only -3.221
Net-Net WC snapshot only $-4.62
EVA snapshot only $-18701710.00
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only B+
Credit Score 40.06 25.66 26.21 26.26 34.20 36.42 33.17 26.07 29.05 24.02 25.55 31.73 38.03 36.66 17.83 21.71 47.59 48.75 36.72 34.05 34.053
Credit Grade snapshot only 14
Credit Trend snapshot only 12.340
Implied Spread (bps) snapshot only 650.000
Industry Credit Rank snapshot only 25
Sector Credit Rank snapshot only 26

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms